ARCHIVES

FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | March 23, 2001

Download PDF Visit The Full Archive

Related Articles

Ten Is The New 12: Medicare Lowers Hemoglobin Targets For ESA Use.

August 3, 2007

Bioassay Backlog Reports show Increasing Number Of Equivocal Results; Is The Program A Failure?

September 2, 1977

In Brief: HHS Implements Debarment Regulations; Joftes, Cain Head New NCI contract, Grants Branches

October 24, 1980

In Brief: Resolution wasn’t Strong Enough, Reizen Though; Two More chemicals reported Out of Bioassay

June 3, 1977

NCI Advisors Discuss Cap On Center Core Grants While Broder Complains Cap Is ‘Anti-Intellectual’

May 17, 1991

First Report On Carcinogens Now Avaiable

October 3, 1980